These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 38703078)
1. Therapeutic potential of cannabidiol (CBD) in the treatment of cardiovascular diseases. Naya NM; Kelly J; Hogwood A; Abbate A; Toldo S Expert Opin Investig Drugs; 2024 Jul; 33(7):699-712. PubMed ID: 38703078 [TBL] [Abstract][Full Text] [Related]
2. The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease. Kicman A; Toczek M Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937917 [TBL] [Abstract][Full Text] [Related]
3. Current Cannabidiol Safety: A Review. Singh C; Rao K; Yadav N; Vashist Y; Chugh P; Bansal N; Minocha N Curr Drug Saf; 2023; 18(4):465-473. PubMed ID: 36056846 [TBL] [Abstract][Full Text] [Related]
4. Molecular and Cellular Mechanisms of Action of Cannabidiol. Martinez Naya N; Kelly J; Corna G; Golino M; Abbate A; Toldo S Molecules; 2023 Aug; 28(16):. PubMed ID: 37630232 [TBL] [Abstract][Full Text] [Related]
5. Is the cardiovascular system a therapeutic target for cannabidiol? Stanley CP; Hind WH; O'Sullivan SE Br J Clin Pharmacol; 2013 Feb; 75(2):313-22. PubMed ID: 22670794 [TBL] [Abstract][Full Text] [Related]
6. Cannabidiol: State of the art and new challenges for therapeutic applications. Pisanti S; Malfitano AM; Ciaglia E; Lamberti A; Ranieri R; Cuomo G; Abate M; Faggiana G; Proto MC; Fiore D; Laezza C; Bifulco M Pharmacol Ther; 2017 Jul; 175():133-150. PubMed ID: 28232276 [TBL] [Abstract][Full Text] [Related]
7. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990 [TBL] [Abstract][Full Text] [Related]
8. Cannabis sativa: Much more beyond Δ Alves P; Amaral C; Teixeira N; Correia-da-Silva G Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286 [TBL] [Abstract][Full Text] [Related]
9. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329 [TBL] [Abstract][Full Text] [Related]
10. Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury. Durst R; Danenberg H; Gallily R; Mechoulam R; Meir K; Grad E; Beeri R; Pugatsch T; Tarsish E; Lotan C Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3602-7. PubMed ID: 17890433 [TBL] [Abstract][Full Text] [Related]
11. The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut. Brown K; Funk K; Figueroa Barrientos A; Bailey A; Shrader S; Feng W; McClain CJ; Song ZH Cells; 2024 Sep; 13(19):. PubMed ID: 39404382 [TBL] [Abstract][Full Text] [Related]
12. Considerations and Implications of Cannabidiol Use During Pregnancy. Sarrafpour S; Urits I; Powell J; Nguyen D; Callan J; Orhurhu V; Simopoulos T; Viswanath O; Kaye AD; Kaye RJ; Cornett EM; Yazdi C Curr Pain Headache Rep; 2020 Jun; 24(7):38. PubMed ID: 32524214 [TBL] [Abstract][Full Text] [Related]
13. A Critical Review of the Role of the Cannabinoid Compounds Δ Jones É; Vlachou S Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776 [TBL] [Abstract][Full Text] [Related]
14. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents. Fasinu PS; Phillips S; ElSohly MA; Walker LA Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147 [TBL] [Abstract][Full Text] [Related]
15. In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties. Perez E; Fernandez JR; Fitzgerald C; Rouzard K; Tamura M; Savile C Molecules; 2022 Jan; 27(2):. PubMed ID: 35056807 [TBL] [Abstract][Full Text] [Related]
16. Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis. Giacoppo S; Soundara Rajan T; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4906-19. PubMed ID: 26744883 [TBL] [Abstract][Full Text] [Related]
17. Unraveling the Mechanisms of Cannabidiol's Pharmacological Actions: A Comprehensive Research Overview. Kalsoom I; Shehzadi K; Li HS; Wen HL; Yu MJ Top Curr Chem (Cham); 2024 Jun; 382(2):20. PubMed ID: 38829467 [TBL] [Abstract][Full Text] [Related]
18. Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway. Koturbash I; MacKay D J Diet Suppl; 2020; 17(5):487-492. PubMed ID: 32715797 [TBL] [Abstract][Full Text] [Related]
19. Antioxidant and anti-apoptotic effects of cannabidiol in model of ischemic stroke in rats. Khaksar S; Bigdeli M; Samiee A; Shirazi-Zand Z Brain Res Bull; 2022 Mar; 180():118-130. PubMed ID: 35031355 [TBL] [Abstract][Full Text] [Related]
20. A molecular basis for the anti-inflammatory and anti-fibrosis properties of cannabidiol. Sunda F; Arowolo A FASEB J; 2020 Nov; 34(11):14083-14092. PubMed ID: 32885502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]